Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentration-Volume Relationship of Bupivacaine in Femoral Nerve Block for TKA
NCT03623230Phase 4Completed
- Sponsor
- Bozyaka Training and Research Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Bozyaka Training and Research Hospital. Primary endpoint: Post-operative pain assessed by Numeric Rating Scale at 48 hours. Started Aug 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03623230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03623230.